Search Within

Emiliano Cocco

Formats
  1. Journal Article (18)
  2. Meeting Abstract (11)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Sloan Kettering Institute Postdocs (31)
  2. Department of Medicine (21)
  3. GSK Faculty (21)
  4. Solid Tumor Oncology Division (21)
  5. Human Oncology and Pathogenesis Program (16)
  6. Department of Pathology and Laboratory Medicine (15)

More Groups

People
  1. Maurizio Scaltriti (25)
  2. David Hyman (13)
  3. Eneda Toska (11)
  4. Alexander Drilon (10)
  5. Sophie Shifman (10)
  6. Jaclyn Hechtman (9)

More People

Years
  1. 2022 (3)
  2. 2021 (2)
  3. 2020 (8)
  4. 2019 (9)
  5. 2018 (6)
  6. 2017 (2)

More Years

Publications
  1. Cancer Research (8)
  2. Clinical Cancer Research (3)
  3. Cancer Discovery (2)
  4. Nature Communications (2)
  5. Annals of Oncology (1)
  6. Blood (1)

More Publications

Publishers
  1. American Association for Cancer Research (13)
  2. Nature Publishing Group (6)
  3. Elsevier Inc. (3)
  4. Cell Press (2)
  5. American Association for the Advancement of Science (1)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers
    Journal Article

    Bonazzoli, E.; Cocco, E.; Lopez, S.; Bellone, S.; Zammataro, L.; Bianchi, A.; Manzano, A.; Yadav, G.; Manara, P.; Perrone, E.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Colorectal carcinomas containing hypermethylated MLH1 promoter and wild-type BRAF/KRAS are enriched for targetable kinase fusions
    Journal Article

    Cocco, E.; Benhamida, J.; Middha, S.; Zehir, A.; Mullaney, K.; Shia, J.; Yaeger, R.; Zhang, L.; Wong, D.; Villafania, L.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Successful tumor formation following xenotransplantation of primary human ovarian cancer cells into severe combined immunodeficient (SCID) pigs
    Meeting Abstract

    Boettcher, A. N.; Kiupel, M.; Adur, M.; Cocco, E.; Santin, A.; Charley, S.; Risinger, J.; Tuggle, C.; Shapiro, E.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • NTRK fusion-positive cancers and TRK inhibitor therapy
    Journal Article

    Cocco, E.; Scaltriti, M.; Drilon, A.
    Nature Reviews Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)
    Journal Article

    Cocco, E.; Carmona, F. J.; Razavi, P.; Won, H. H.; Cai, Y.; Rossi, V.; Chan, C.; Cownie, J.; Soong, J.; Toska, E.; more...
    Science Signaling (2018)

    Fulltext@MSK | Save
  • Inhibition of BET bromodomain proteins with GS-5829 and GS-626510 in uterine serous carcinoma, a biologically aggressive variant of endometrial cancer
    Journal Article

    Bonazzoli, E.; Predolini, F.; Cocco, E.; Bellone, S.; Altwerger, G.; Menderes, G.; Zammataro, L.; Bianchi, A.; Pettinella, F.; Riccio, F.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies
    Journal Article

    Taylor, J.; Pavlick, D.; Yoshimi, A.; Marcelus, C.; Chung, S. S.; Hechtman, J. F.; Benayed, R.; Cocco, E.; Durham, B. H.; Bitner, L.; more...
    Journal of Clinical Investigation (2018)

    Fulltext@MSK | Save
  • Potential recurrence markers of locally advanced triple negative breast cancer treated by combined neoadjuvant EGFR targeting and chemotherapy, revealed by genomic analyses and assessment of tumor-infiltrating lymphocytes
    Meeting Abstract

    Radosevic-Robin, N.; Cocco, E.; Privat, M.; Abrial, C.; Penault-Llorca, F.; Scaltriti, M.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Characterization of NTRK fusions and therapeutic response to NTRK inhibition in hematologic malignancies
    Meeting Abstract

    Taylor, J.; Marcelus, C.; Pavlick, D.; Benayed, R.; Yoshimi, A.; Cocco, E.; Durham, B. H.; Hechtman, J. F.; Chung, Y. R.; Mullaney, K.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Genomic analyses reveal potential recurrence markers of locally advanced triple negative breast cancer treated by combined neoadjuvant EGFR targeting and chemotherapy
    Meeting Abstract

    Radosevic-Robin, N.; Cocco, E.; Won, H. H.; Berger, M. F.; Privat, M.; Abrial, C.; Penault-Llorca, F.; Scaltriti, M.
    Annals of Oncology (2017)

    Fulltext@MSK | Save